AmSurg receives ‘buy’ rating — 5 quick facts

Eleven analysts gave AmSurg shares a “buy” rating, according to The Vista Voice.

Advertisement

Here are five quick facts:

1. Analysts have a 12-month price target of $89.78 on AmSurg shares.

2. On April 13, AmSurg shares opened at $76.02.

3. The company’s market cap is $4.07 billion.

4. AmSurg has a 50-day moving average of $72.12 and 200-day moving average of $75.26.

5. The company has a P/E ratio of 24.08.

More articles on surgery centers:
7 new joint venture ASCs — March/April 2016
Stamford ASC opens in Connecticut — 5 highlights
Mercy Health’s plans for outpatient center advance — 5 points

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Is ambulatory care healthcare’s big margin engine? 4 leaders weigh in

Wednesday, July 29
1:00 PM - 2:00 PM CDT

Presenters: Joe Ganley, athenahealthJeffrey Flynn, CASC, Gramercy Surgery CenterBryan Tsao, Access Center, Loma Linda University HealthJason Zepeda, Northridge Hospital Medical Center, CommonSpirit HealthGreg DeConciliis, PA-C, CASC, Boston Out­Patient Surgical Suites

Advertisement

Next Up in ASC Transactions & Valuation Issues

Advertisement

Comments are closed.